JPRN-UMIN000017751
Completed
未知
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer. - Phase I/II study of GEM + nab-PTX + radiation therapy in patients with pancreatic cancer.
Department of Surgery, Keio University School of Medicine0 sites30 target enrollmentMay 31, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Surgery, Keio University School of Medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)bowel movement control is difficult, because of watery diarrhea and chronic diarrhea. (2\)Interstitial pneumonia or pulmonary fibrosis diagnosed by chest X\-ray and with symptom (3\)Pleural effusion or ascitic fluid accumulates (4\)with clinically important infection (5\)has active carcinoma except carcinoma in situ (6\)with gastrointestinal active ulcer (7\)sever complication(heart failure, renal failure,liver failure,intestinal paralysis,uncontrollable diabetes etc) (8\)severe mental disorder (9\)severe drug allergy (10\)pregnant women or during the nursing, women who like be pregnant and willing to get pregnant (11\)doctors decision not to be registered to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerJPRN-UMIN000026525Chiba Cancer Center30
Completed
Not Applicable
Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000030551Mie university15
Active, not recruiting
Phase 1
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
Completed
Phase 2
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
Completed
Phase 2
Phase II study of gemcitabine plus nab-Pacletaxel as second-line therapy after FOLFIRINOX for advanced pancreatic canceradvanced pancreatic cancerJPRN-UMIN000016624Gifu University Hospital30